Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > An article on lung cancer

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Jul 27, 2021 9:43am

185 Views

Post# 33609460

RE:An article on lung cancer

Yes FG - why didn’t Roswell run with TLD-1433 in those Trials? Did Theralase refuse them the licence? Are TLT themselves being denied use of the sensitisers licenced to them but developed by Sherri on US campuses? Is there some sort of stand off here to the benefit of Big Pharma?

<< Previous

Bullboard Posts

Next >>

AI companies to invest in